100 related articles for article (PubMed ID: 19137788)
1. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
[TBL] [Abstract][Full Text] [Related]
3. [Expression of the protein marker p16INK4a in the cervix uteri cancer].
Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; Spitkovskiĭ DD
Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
Dehn D; Torkko KC; Shroyer KR
Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
[TBL] [Abstract][Full Text] [Related]
5. [Expression of p16INK4a in various cancer cells].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Frank GA; Golovina DA; Spitkovskiĭ DD
Arkh Patol; 2004; 66(5):3-5. PubMed ID: 15575375
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.
Muller S; Flores-Staino C; Skyldberg B; Hellström AC; Johansson B; Hagmar B; Wallin KL; Andersson S
Int J Oncol; 2008 Feb; 32(2):333-40. PubMed ID: 18202755
[TBL] [Abstract][Full Text] [Related]
7. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
[TBL] [Abstract][Full Text] [Related]
8. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
9. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
10. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections.
von Knebel Doeberitz M; Reuschenbach M; Schmidt D; Bergeron C
Expert Rev Proteomics; 2012 Apr; 9(2):149-63. PubMed ID: 22462787
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
13. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
14. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
[TBL] [Abstract][Full Text] [Related]
15. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
16. EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women.
El Hamdani W; Amrani M; Attaleb M; Laantri N; Ennaji MM; Khyatti M; El Mzibri M
Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1373-84. PubMed ID: 20937225
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of efficacy of combined use of liquid cytology and immunohistochemical assay of p16ink4 and standard procedure and high risk evaluation by polymerase chain reaction of human papillomavirus infection in diagnosing cervical dysplasia and carcinoma].
Raskin GA; Petrov SV; Orlova RV; Mal'tseva LI; Akhmetzianova AV; Farrakhova LN; Khasanov RSh
Vopr Onkol; 2009; 55(2):192-5. PubMed ID: 19514374
[TBL] [Abstract][Full Text] [Related]
18. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
[TBL] [Abstract][Full Text] [Related]
19. [Cervix dysplasia and cervix carcinoma].
Bol P
Ned Tijdschr Tandheelkd; 1998 Dec; 105(12):455-6. PubMed ID: 11928150
[No Abstract] [Full Text] [Related]
20. The use of p16 as a marker for cervical cancer precursor lesions.
O'Connor DM
J Low Genit Tract Dis; 2007 Apr; 11(2):67-8. PubMed ID: 17415108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
